- Home
- BBIO vs BYD Comparison
BBIO vs BYD Comparison
Compare BBIO & BYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBIO
- BYD
- Stock Information
- Founded
- BBIO 2015
- BYD 1973
- Country
- BBIO United States
- BYD United States
- Employees
- BBIO N/A
- BYD N/A
- Industry
- BBIO Biotechnology: Pharmaceutical Preparations
- BYD Hotels/Resorts
- Sector
- BBIO Health Care
- BYD Consumer Discretionary
- Exchange
- BBIO Nasdaq
- BYD Nasdaq
- Market Cap
- BBIO 7.6B
- BYD 6.1B
- IPO Year
- BBIO 2019
- BYD 1993
- Fundamental
- Price
- BBIO $41.73
- BYD $76.43
- Analyst Decision
- BBIO Strong Buy
- BYD Buy
- Analyst Count
- BBIO 13
- BYD 13
- Target Price
- BBIO $56.67
- BYD $80.42
- AVG Volume (30 Days)
- BBIO 2.5M
- BYD 799.0K
- Earning Date
- BBIO 07-31-2025
- BYD 07-24-2025
- Dividend Yield
- BBIO N/A
- BYD 0.94%
- EPS Growth
- BBIO N/A
- BYD 9.82
- EPS
- BBIO N/A
- BYD 6.13
- Revenue
- BBIO $127,415,000.00
- BYD $3,961,238,000.00
- Revenue This Year
- BBIO $102.05
- BYD $1.65
- Revenue Next Year
- BBIO $54.69
- BYD $2.15
- P/E Ratio
- BBIO N/A
- BYD $12.51
- Revenue Growth
- BBIO N/A
- BYD 6.06
- 52 Week Low
- BBIO $21.62
- BYD $51.62
- 52 Week High
- BBIO $41.90
- BYD $80.50
- Technical
- Relative Strength Index (RSI)
- BBIO 69.82
- BYD 62.04
- Support Level
- BBIO $39.65
- BYD $73.00
- Resistance Level
- BBIO $41.36
- BYD $75.94
- Average True Range (ATR)
- BBIO 1.51
- BYD 1.33
- MACD
- BBIO 0.35
- BYD -0.01
- Stochastic Oscillator
- BBIO 97.37
- BYD 94.90
About BBIO BridgeBio Pharma Inc.
BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis) , is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.
About BYD Boyd Gaming Corporation
Boyd Gaming Corp is a multi-jurisdictional gaming company. The company operates wholly-owned gaming entertainment properties (casino space, slot machines, table games, and hotel rooms) in Nevada, Illinois, Indiana, Iowa, Kansas, Louisiana, Mississippi, Missouri, Ohio, and Pennsylvania. Geographical regions separate its business segments: Las Vegas Locals, Downtown Las Vegas, Midwest and South, and Online. Midwest and South hold the key number of entertainment properties, and it generate the majority of sales for the company.